Sentry LLC’s Medtronic MDT Stock Holding History

Sentry LLC’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.06M	Hold	13,604	–	–	0.3%	43
2026 Q1	$1.18M	Hold	13,604	–	–	0.38%	35
2025 Q4	$1.31M	Hold	13,604	–	–	0.36%	32
2025 Q3	$1.3M	Hold	13,604	–	–	0.32%	35
2025 Q2	$1.19M	Hold	13,604	–	–	0.24%	35
2025 Q1	$1.22M	Buy	13,604 +1,358	+11%	+$122K	0.24%	34
2024 Q4	$978K	Sell	12,246 -1,358	-10%	-$118K	0.19%	40
2024 Q3	$1.22M	Hold	13,604	–	–	0.24%	34
2024 Q2	$1.07M	Hold	13,604	–	–	0.2%	35
2024 Q1	$1.19M	Sell	13,604 -4	-0%	-$341	0.22%	32
2023 Q4	$1.12M	Sell	13,608 -36	-0.3%	-$2.74K	0.24%	30
2023 Q3	$1.07M	Hold	13,644	–	–	0.23%	34
2023 Q2	$1.2M	Hold	13,644	–	–	0.26%	32
2023 Q1	$1.1M	Buy	+13,644	New	+$1.11M	0.26%	36

Other funds holding MDT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Sentry LLC's MDT Position: Q2 2026 in Review

Sentry LLC held its Medtronic (MDT) position steady in Q2 2026 at 13,604 shares worth $1.06M. The position accounts for 0.3% of the portfolio, ranked #43.

Sentry LLC first reported a position in MDT in Q1 2023 and has held it in 14 quarters since. The position peaked at $1.31M in Q4 2025. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

Sentry LLC held 13,604 shares of Medtronic worth $1.06M as of Q2 2026.
Sentry LLC left its Medtronic share count unchanged in Q2 2026.
Medtronic made up 0.3% of Sentry LLC's portfolio in Q2 2026, its #43 holding.
Sentry LLC first reported a position in Medtronic in Q1 2023 and has held it in 14 quarters since.
Sentry LLC's Medtronic position peaked at $1.31M in Q4 2025.
2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Sentry LLC's 13F filing for Q2 2026, filed 14 Aug 2026.